GS Paper 2

China

18th June – Reset ties with China

Reset ties with China With its aggression in the Galwan Valley, Ladakh, China has crossed a threshold and pushed the relationship with India to a dangerous low, with long-lasting consequences. The events – Chinese soldiers used the opportunity of a negotiated withdrawal operation to viciously attack a supervisory Indian contingent. The first Indian military casualties …

18th June – Reset ties with China Read More »

China

17th June – Remaining non-aligned

Remaining non-aligned is good advice For weeks, the India-China stand-off has dominated the national discourse now which warns about the possibility of a major conflict along the Line of Actual Control (LAC) in the Ladakh and Sikkim sectors. Why the conflict is happening? Border infrastructure – Both India and China have been strengthening their border …

17th June – Remaining non-aligned Read More »

Discrimination

16th June – Anti-discrimination law

The need for an anti-discrimination law In our country, the problem of racism is exacerbated by other historically ingrained forms of discrimination, along the lines of caste, class, gender, and religion among other things. Defining private discrimination – These prejudices, which pervade every aspect of life, from access to basic goods, to education and employment, …

16th June – Anti-discrimination law Read More »

Diplomacy

15th June – India’s medicine diplomacy

India’s medicine diplomacy “Vasudhaiv Kutumbakam” (World is one family) has been a key ingredient of India’s outreach to the world from time immemorial. It has also acquired a greater salience in the wake of Covid-19 pandemic. India has its own problems even if it had taken early measures to counter the pandemic. However, India’s recent …

15th June – India’s medicine diplomacy Read More »

Privatisation

13th June – Privatisation of PSBs

Privatisation is not a panacea for PSBs If news reports are to be believed, the government is likely to designate banking as a strategic sector under the new privatisation policy. This will allow the government to own a maximum of four public sector banks (PSBs), and thus, some PSBs which have not been included in …

13th June – Privatisation of PSBs Read More »

G7

12th June – Unravelling the G7

An unravelling of the Group of Seven (G7) The G7 Summit scheduled in Washington DC was recently postponed by the US President Donald Trump.  What did President Trump say? While postponing the summit “to at least September”, Mr. Trump declared that in any case, the G7 “is a very outdated group of countries” and no …

12th June – Unravelling the G7 Read More »

Urban governance

11th June – Urban governance reforms

Urban governance systems must reform A comparative analysis of the emerging coronavirus cases across India clearly shows that rural areas have fared extremely well in comparison to urban areas in enforcing the various Ministry of Home Affairs guidelines related to the lockdowns and, consequently, in containing the overall spread of COVID-19. It can also be …

11th June – Urban governance reforms Read More »

e-diplomacy

10th June – e-diplomacy

The e-diplomacy experiment The first India-Australia virtual leaders’ summit on June 4 had a lot on the menu, ranging from military interoperability to jointly tackling COVID-19. The two countries upgraded their relations to a ‘comprehensive strategic partnership’. The summit was noteworthy for its novel modus operandi. E-diplomacy – Just as corporations and educational institutions have …

10th June – e-diplomacy Read More »

Persian Gulf

9th June – Cooperative Security in Persian Gulf

In Persian Gulf littoral, cooperative security is key The United Nations defines this body of water as the Persian Gulf. The lands around it are shared by eight countries (Bahrain, Iran, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates), all members of the UN. There is a commonality of interest among them …

9th June – Cooperative Security in Persian Gulf Read More »

Pharma

8th June – R&D in Pharma

A right time to shift pharma gears Commercial pharma research and development (R&D) efforts are encouraged and rewarded through the earnings that innovators derive from sales of their branded products. To be sure, before such huge markups can yield any profits, commercial pharmaceutical innovators must first cover their large R&D costs, including the cost of …

8th June – R&D in Pharma Read More »